BioAge Labs reports positive trial results for the treatment of muscle atrophy
The company plans to begin a Phase II trial in the prevention of ICU diaphragmatic atrophy and critical illness myopathy.
Analysis
Next on diversity: inclusion of participants with cognitive impairment in clinical trials
Alzheimer’s disease drug development: three major questions for 2023
Pipeline Moves: Novartis completes ulcerative colitis trial, advancement prospects rise
Study shows high prevalence of hypertension among Indian children and teens
Petition to update US alcohol warning label could prevent many cancer cases
Friedreich’s ataxia: major trial readouts and regulatory events to watch in 2023
A third of all schizophrenia cases go undiagnosed
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
